BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1086597)

  • 1. In vivo dissociation of factor VII (AHF) activity and factor VII-related antigen in von Willebrand's disease.
    Lian EC; Deykin D
    Am J Hematol; 1976; 1(1):71-8. PubMed ID: 1086597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis.
    Zimmerman TS; Hoyer LW; Dickson L; Edgington TS
    J Lab Clin Med; 1975 Jul; 86(1):152-9. PubMed ID: 1080496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The factor VIII abnormality in severe von Willebrand's disease.
    Zimmerman TS; Abildgaard CF; Meyer D
    N Engl J Med; 1979 Dec; 301(24):1307-10. PubMed ID: 315519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired von Willebrand's disease in association with Wilm's tumor: regression following treatment.
    Scott JP; Montgomery RR; Tubergen DG; Hays T
    Blood; 1981 Oct; 58(4):665-9. PubMed ID: 6268230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
    Sultan Y; Simeon J; Maisonneuve P; Caen JP
    Thromb Haemost; 1976 Feb; 35(1):110-9. PubMed ID: 1085498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of von Willebrand's disease revisited.
    Bowie EJ; Fass DN; Olson JD; Owen CA
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of von Willebrand's disease].
    Baklaja R; Stojimirović E; Kezić J; Cuperlović K; Jovanović B; Cvetković V; Rasović N; Stajić M
    Bilt Hematol Transfuz; 1977; 5(3-4):41-61. PubMed ID: 307953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two populations of factor VIII-related antigen in a family with von Willebrand's disease.
    Armitage H; Rizza CR
    Br J Haematol; 1979 Feb; 41(2):279-89. PubMed ID: 311651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Von Willebrand's syndrome (author's transl)].
    Larrieu MJ; Meyer D; Ardaillou N
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):371-82. PubMed ID: 303357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay.
    Ness PM; Hymas PG; Perkins HA
    Am J Clin Pathol; 1979 Jan; 71(1):26-30. PubMed ID: 311154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of epinephrine infusion in patients with von Willebrand's disease.
    Rickles FR; Hoyer LW; Rick ME; Ahr DJ
    J Clin Invest; 1976 Jun; 57(6):1618-25. PubMed ID: 1084352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on molecular size distribution of factor VIII-related antigen in patients with Von Willebrand's disease and their parents].
    Mikami S; Nishino M; Yasui M; Okubo Y; Shima H; Fukui H
    Rinsho Ketsueki; 1982 Aug; 23(8):1198-204. PubMed ID: 6815349
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new variant of dominant type II von Willebrand's disease with aberrant multimeric pattern of factor VIII-related antigen (type IID).
    Kinoshita S; Harrison J; Lazerson J; Abildgaard CF
    Blood; 1984 Jun; 63(6):1369-71. PubMed ID: 6426551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.